To mature in mind alone, without the aches, pains, wrinkles, and ailments that emerge as our cells break down over time. Sam Altman, of OpenAI fame, invested $180 million in a niche startup that is trying to extend human lifespan by 10 years. Peter Thiel invested in Unity Biotechnology, which is studying senescent cells — cells that do not break down as we age. AdvertisementBusiness Insider's "Forever Young" explores the many ways we as a society are pursuing longer, healthier lives. From new drugs to supplements to lifestyle tweaks to scientific experiments, here's how scientists — and everyday people — are trying to turn back the clock on aging.

---

Persons: Jeff Bezos, Sam Altman, Peter Thiel Organizations: Altos Labs, Unity Biotechnology